{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:54:24Z","timestamp":1789095264794,"version":"build-2803163510"},"reference-count":90,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Migraine and stroke are neurological disorders with significant global prevalence and impact. Recent advances in migraine therapy have focused on the calcitonin gene-related peptide (CGRP) pathway. This review examines the shared pathomechanisms between migraine and stroke, with emphasis on the role of CGRP. We analyze the current literature on CGRP\u2019s functions in cerebrovascular regulation, edema formation, neuroinflammation, and neuroprotection. CGRP acts as a potent vasodilator and plays a crucial role in trigeminovascular activation during migraine attacks. In stroke, CGRP has demonstrated neuroprotective effects by improving collateral circulation and reducing ischemia-reperfusion injury. Concerns have been raised about the potential impact of CGRP inhibitors on stroke risk and outcomes. Studies in animals suggest that CGRP receptor antagonists may worsen cerebral ischemia by impairing collateral flow. We discuss the implications of these findings for the use of CGRP-targeting therapies in migraine patients, especially those at increased risk of stroke. Additionally, we explore the complex interplay between CGRP, endothelial function, and platelet activity in both conditions. This review highlights the need for further research to elucidate the long-term cerebrovascular safety of CGRP pathway inhibitors and to identify potential subgroups of migraine patients who may be at higher risk of adverse cerebrovascular events with these novel therapies.<\/jats:p>","DOI":"10.3390\/ijms252111685","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T06:55:37Z","timestamp":1730357737000},"page":"11685","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Novel Calcitonin Gene-Related Peptide (CGRP) Interfering Migraine Therapies and Stroke\u2014A Review"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9986-8392","authenticated-orcid":false,"given":"Michael Thomas","family":"Eller","sequence":"first","affiliation":[{"name":"Department of Neurology, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Frank","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Kaltseis","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3075-5437","authenticated-orcid":false,"given":"Anel","family":"Karisik","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Innsbruck, 6020 Innsbruck, Austria"},{"name":"VASCage\u2014Centre on Clinical Stroke Research, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Knoflach","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Innsbruck, 6020 Innsbruck, Austria"},{"name":"VASCage\u2014Centre on Clinical Stroke Research, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Broessner","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.brainres.2014.11.031","article-title":"Localization of CGRP, CGRP Receptor, PACAP and Glutamate in Trigeminal Ganglion. Relation to the Blood-Brain Barrier","volume":"1600","author":"Eftekhari","year":"2015","journal-title":"Brain Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCRESAHA.123.321673","article-title":"Clinical Potential of Adrenomedullin Signaling in the Cardiovascular System","volume":"132","author":"Balint","year":"2023","journal-title":"Circ. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3988\/jcn.2012.8.2.89","article-title":"Sensitization of the Trigeminovascular Pathway: Perspective and Implications to Migraine Pathophysiology","volume":"8","author":"Bernstein","year":"2012","journal-title":"J. Clin. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Altamura, C., and Vernieri, F. (2021). Commentary: Enhanced Hemodynamic and Clinical Response to ACGRP in Migraine Patients\u2014A TCD Study. Front. Neurol., 12.","DOI":"10.3389\/fneur.2021.663818"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Okutsu, Y., Takahashi, Y., Nagase, M., Shinohara, K., Ikeda, R., and Kato, F. (2017). Potentiation of NMDA Receptor-Mediated Synaptic Transmission at the Parabrachial-Central Amygdala Synapses by CGRP in Mice. Mol. Pain, 13.","DOI":"10.1177\/1744806917709201"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Carter, S.C., Cucchiara, B., Reehal, N., Hamilton, K., Kaiser, E.A., and Favilla, C.G. (2024). Effect of CGRP Inhibitors on Interictal Cerebral Hemodynamics in Individuals with Migraine. Front. Neurol., 15.","DOI":"10.3389\/fneur.2024.1399792"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/HJH.0000000000001649","article-title":"Endogenous Calcitonin Gene-Related Peptide Suppresses Ischemic Brain Injuries and Progression of Cognitive Decline","volume":"36","author":"Zhai","year":"2018","journal-title":"J. Hypertens."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejphar.2018.03.031","article-title":"Independent Roles of CGRP in Cardioprotection and Hemodynamic Regulation in Ischemic Postconditioning","volume":"828","author":"Guo","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Sorby-Adams, A.J., Marcoionni, A.M., Dempsey, E.R., Woenig, J.A., and Turner, R.J. (2017). The Role of Neurogenic Inflammation in Blood-Brain Barrier Disruption and Development of Cerebral Oedema Following Acute Central Nervous System (CNS) Injury. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18081788"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Zarban, A.A., Chaudhry, H., de Sousa Valente, J., Argunhan, F., Ghanim, H., and Brain, S.D. (2022). Elucidating the Ability of CGRP to Modulate Microvascular Events in Mouse Skin. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232012246"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.neuroscience.2010.05.016","article-title":"Differential Distribution of Calcitonin Gene-Related Peptide and Its Receptor Components in the Human Trigeminal Ganglion","volume":"169","author":"Eftekhari","year":"2010","journal-title":"Neuroscience"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s10194-022-01425-9","article-title":"Characterization of Erenumab and Rimegepant on Calcitonin Gene-Related Peptide Induced Responses in Xenopus Laevis Oocytes Expressing the Calcitonin Gene-Related Peptide Receptor and the Amylin-1 Receptor","volume":"23","author":"Juhler","year":"2022","journal-title":"J. Headache Pain"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","article-title":"Global, Regional, and National Burden of Disorders Affecting the Nervous System, 1990\u20132021: A Systematic Analysis for the Global Burden of Disease Study 2021","volume":"23","author":"Steinmetz","year":"2024","journal-title":"Lancet Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1046\/j.1468-2982.2000.00146.x","article-title":"Nitric Oxide Metabolites, Prostaglandins and Trigeminal Vasoactive Peptides in Internal Jugular Vein Blood during Spontaneous Migraine Attacks","volume":"20","author":"Sarchielli","year":"2000","journal-title":"Cephalalgia"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1177\/0333102419856640","article-title":"Calcitonin Gene-Related Peptide Levels in Tear Fluid Are Elevated in Migraine Patients Compared to Healthy Controls","volume":"39","author":"Kamm","year":"2019","journal-title":"Cephalalgia"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1212\/WNL.0b013e3182a6cb72","article-title":"Interictal Increase of CGRP Levels in Peripheral Blood as a Biomarker for Chronic Migraine","volume":"81","author":"Larrosa","year":"2013","journal-title":"Neurology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1177\/0333102410368444","article-title":"Calcitonin Gene-Related Peptide Triggers Migraine-like Attacks in Patients with Migraine with Aura","volume":"30","author":"Hansen","year":"2010","journal-title":"Cephalalgia"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1097\/j.pain.0000000000000702","article-title":"Premonitory and Nonheadache Symptoms Induced by CGRP and PACAP38 in Patients with Migraine","volume":"157","author":"Guo","year":"2016","journal-title":"Pain"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3331024231152169","DOI":"10.1177\/03331024231152169","article-title":"Safety and Tolerability of Monoclonal Antibodies Targeting the CGRP Pathway and Gepants in Migraine Prevention: A Systematic Review and Network Meta-Analysis","volume":"43","author":"Messina","year":"2023","journal-title":"Cephalalgia"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1177\/0333102420983282","article-title":"Migraine Therapeutics Differentially Modulate the CGRP Pathway","volume":"41","author":"Bhakta","year":"2021","journal-title":"Cephalalgia"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/sj.bjp.0707134","article-title":"Inhibitory Effect of BIBN4096BS, CGRP 8-37, a CGRP Antibody and an RNA-Spiegelmer on CGRP Induced Vasodilatation in the Perfused and Non-Perfused Rat Middle Cerebral Artery","volume":"150","author":"Edvinsson","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s10194-015-0575-8","article-title":"Experimental Inflammation Following Dural Application of Complete Freund\u2019s Adjuvant or Inflammatory Soup Does Not Alter Brain and Trigeminal Microvascular Passage","volume":"16","author":"Lundblad","year":"2015","journal-title":"J. Headache Pain"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/0333102419896760","article-title":"Fluorescently-Labeled Fremanezumab Is Distributed to Sensory and Autonomic Ganglia and the Dura but Not to the Brain of Rats with Uncompromised Blood Brain Barrier","volume":"40","author":"Noseda","year":"2020","journal-title":"Cephalalgia"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1124\/jpet.109.163816","article-title":"Pharmacological Properties of MK-3207, a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist","volume":"333","author":"Salvatore","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1177\/0333102420914913","article-title":"No Central Action of CGRP Antagonising Drugs in the GTN Mouse Model of Migraine","volume":"40","author":"Christensen","year":"2020","journal-title":"Cephalalgia"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1056\/NEJMoa1813049","article-title":"Ubrogepant for the Treatment of Migraine","volume":"381","author":"Dodick","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1474-4422(22)00517-8","article-title":"Safety, Tolerability, and Efficacy of Zavegepant 10 Mg Nasal Spray for the Acute Treatment of Migraine in the USA: A Phase 3, Double-Blind, Randomised, Placebo-Controlled Multicentre Trial","volume":"22","author":"Lipton","year":"2023","journal-title":"Lancet Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1212\/WNL.0000000000201699","article-title":"Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update","volume":"100","author":"Sacco","year":"2023","journal-title":"Neurology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/jnnp-2018-318254","article-title":"Migraine and Risk of Stroke","volume":"91","author":"Kurth","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1001\/jama.2020.7172","article-title":"Association of Migraine With Aura and Other Risk Factors with Incident Cardiovascular Disease in Women","volume":"323","author":"Kurth","year":"2020","journal-title":"JAMA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e1694","DOI":"10.1212\/WNL.0000000000201009","article-title":"Vascular Risk Score and Associations with Past, Current, or Future Migraine in Women: Cohort Study","volume":"99","author":"Ibrahimi","year":"2022","journal-title":"Neurology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/STROKEAHA.117.020160","article-title":"Frequency of Patent Foramen Ovale and Migraine in Patients with Cryptogenic Stroke","volume":"49","author":"West","year":"2018","journal-title":"Stroke"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"k96","DOI":"10.1136\/bmj.k96","article-title":"Migraine and Risk of Cardiovascular Diseases: Danish Population Based Matched Cohort Study","volume":"360","author":"Adelborg","year":"2018","journal-title":"BMJ"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/ene.14556","article-title":"Cardiac Sources of Cerebral Embolism in People with Migraine","volume":"28","author":"Grassi","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jamaneurol.2016.5704","article-title":"Association Between Migraine and Cervical Artery Dissection: The Italian Project on Stroke in Young Adults","volume":"74","author":"Grassi","year":"2017","journal-title":"JAMA Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1212\/01.wnl.0000294329.93565.94","article-title":"Decreased Number and Function of Endothelial Progenitor Cells in Patients with Migraine","volume":"70","author":"Lee","year":"2008","journal-title":"Neurology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/0333102412469737","article-title":"Analysis of Endothelial Precursor Cells in Chronic Migraine: A Case-Control Study","volume":"33","author":"Oterino","year":"2013","journal-title":"Cephalalgia"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/0333102414529671","article-title":"Circulating Endothelial Microparticles in Female Migraineurs with Aura","volume":"35","author":"Liman","year":"2015","journal-title":"Cephalalgia"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/0333102417698936","article-title":"Migraine and Vascular Disease Biomarkers: A Population-Based Case-Control Study","volume":"38","author":"Tietjen","year":"2018","journal-title":"Cephalalgia"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1177\/0333102414564890","article-title":"Markers of Endothelial Function in Migraine Patients: Results from a Bi-Center Prospective Study","volume":"35","author":"Fischer","year":"2015","journal-title":"Cephalalgia"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1212\/WNL.57.2.334","article-title":"Increased von Willebrand Factor in Migraine","volume":"57","author":"Tietjen","year":"2001","journal-title":"Neurology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.thromres.2005.12.020","article-title":"Altered Hemostasis in Migraineurs Studied with a Dynamic Flow System","volume":"119","author":"Tietjen","year":"2007","journal-title":"Thromb. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1468-2982.2008.01824.x","article-title":"Association of von Willebrand Factor Activity with ACE I\/D and MTHFR C677T Polymorphisms in Migraine","volume":"29","author":"Tietjen","year":"2009","journal-title":"Cephalalgia"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1468-2982.2007.01324.x","article-title":"Increased C-Reactive Protein in Young Adult Patients with Migraine","volume":"27","author":"Vanmolkot","year":"2007","journal-title":"Cephalalgia"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1161\/STROKEAHA.109.547901","article-title":"Migraine and Biomarkers of Endothelial Activation in Young Women","volume":"40","author":"Tietjen","year":"2009","journal-title":"Stroke"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.04.007","article-title":"Vascular Risk Factors, Endothelial Function, and Carotid Thickness in Patients with Migraine: Relationship to Atherosclerosis","volume":"19","author":"Hamed","year":"2010","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"357","DOI":"10.5114\/ninp.2013.36760","article-title":"Evaluation of Serum Transforming Growth Factor \u03921 and C-Reactive Protein Levels in Migraine Patients","volume":"47","author":"Celik","year":"2013","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_48","first-page":"e1076","article-title":"Iron Deposition in Periaqueductal Gray Matter as a Potential Biomarker for Chronic Migraine","volume":"92","author":"Villalba","year":"2019","journal-title":"Neurology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/0333102414550416","article-title":"Adverse Cardiovascular Events Associated with Triptans and Ergotamines for Treatment of Migraine: Systematic Review of Observational Studies","volume":"35","author":"Roberto","year":"2015","journal-title":"Cephalalgia"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"107528","DOI":"10.1016\/j.pharmthera.2020.107528","article-title":"Pharmacological Treatment of Migraine: CGRP and 5-HT beyond the Triptans","volume":"211","author":"MaassenVanDenBrink","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/0333102418774299","article-title":"Cortical Spreading Depression as a Site of Origin for Migraine: Role of CGRP","volume":"39","author":"Close","year":"2019","journal-title":"Cephalalgia"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e14595","DOI":"10.1111\/cns.14595","article-title":"Effect of Anti-CGRP-Targeted Therapy on Migraine Aura: Results of an Observational Case Series Study","volume":"30","author":"Cresta","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/WNP.0000000000000648","article-title":"Cortical Spreading Depression Phenomena Are Frequent in Ischemic and Traumatic Penumbra: A Prospective Study in Patients with Traumatic Brain Injury and Large Hemispheric Ischemic Stroke","volume":"38","author":"Sueiras","year":"2021","journal-title":"J. Clin. Neurophysiol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Chang, C.L., Cai, Z., and Hsu, S.Y.T. (2022). Sustained Activation of CLR\/RAMP Receptors by Gel-Forming Agonists. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232113408"},{"key":"ref_55","first-page":"274","article-title":"The Effects of Calcitonin Gene-Related Peptide on BFGF and AQP4 Expression after Focal Cerebral Ischemia Reperfusion in Rats","volume":"65","author":"Liu","year":"2010","journal-title":"Pharmazie"},{"key":"ref_56","first-page":"17","article-title":"The Assessment of Vasoactive Properties of CGRP and Adrenomedullin in the Microvasculature: A Study Using in Vivo and in Vitro Assays in the Mouse","volume":"221","author":"Tam","year":"2004","journal-title":"J. Mol. Neurosci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1681.2004.03943.x","article-title":"Importance of Calcitonin Gene-Related Peptide, Adenosine and Reactive Oxygen Species in Cerebral Autoregulation under Normal and Diseased Conditions","volume":"31","author":"Shin","year":"2004","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainresbull.2016.11.012","article-title":"Adrenomedullin and Angiotensin II Signaling Pathways Involved in the Effects on Cerebellar Antioxidant Enzymes Activity","volume":"128","author":"Leticia","year":"2017","journal-title":"Brain Res. Bull."},{"key":"ref_59","first-page":"904","article-title":"Pharmacological Preconditioning of the Brain: A Possible Interplay between Opioid and Calcitonin Gene Related Peptide Transduction Systems","volume":"60","author":"Rehni","year":"2008","journal-title":"Pharmacol. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"09636897211035715","DOI":"10.1177\/09636897211035715","article-title":"Mesenchymal Stem Cell-Induced Anti-Neuroinflammation Against Traumatic Brain Injury","volume":"30","author":"Cozene","year":"2021","journal-title":"Cell Transpl."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cjtee.2023.06.002","article-title":"Calcitonin Gene-Related Peptide Inhibits Neuronal Apoptosis in Heatstroke Rats via PKA\/p-CREB Pathway","volume":"27","author":"Zhu","year":"2024","journal-title":"Chin. J. Traumatol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Xiong, J., Wang, Z., Bai, J., Cheng, K., Liu, Q., and Ni, J. (2023). Calcitonin Gene-Related Peptide: A Potential Protective Agent in Cerebral Ischemia\u2013Reperfusion Injury. Front. Neurosci., 17.","DOI":"10.3389\/fnins.2023.1184766"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3892\/br.2016.658","article-title":"Calcitonin Gene-Related Peptide Protects Rats from Cerebral Ischemia\/Reperfusion Injury via a Mechanism of Action in the MAPK Pathway","volume":"4","author":"Yang","year":"2016","journal-title":"Biomed. Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12028-022-01444-z","article-title":"Conditional Vasospasm-Free Survival Following Aneurysmal Subarachnoid Hemorrhage","volume":"37","author":"Kelly","year":"2022","journal-title":"Neurocrit. Care"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/0333102420956692","article-title":"Erenumab Does Not Alter Cerebral Hemodynamics and Endothelial Function in Migraine without Aura","volume":"41","author":"Altamura","year":"2021","journal-title":"Cephalalgia"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s10194-022-01470-4","article-title":"Safety and Tolerability of Erenumab in Individuals with Episodic or Chronic Migraine across Age Groups: A Pooled Analysis of Placebo-Controlled Trials","volume":"23","author":"Lampl","year":"2022","journal-title":"J. Headache Pain"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/head.14485","article-title":"Evaluation of Vascular Risk in Patients with Migraine with and without Aura Treated with Erenumab: Post Hoc Analysis of Pooled Long-Term Clinical Trial Data","volume":"63","author":"Kudrow","year":"2023","journal-title":"Headache"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3331024231159366","DOI":"10.1177\/03331024231159366","article-title":"Evaluating the Efficacy of CGRP MAbs and Gepants for the Preventive Treatment of Migraine: A Systematic Review and Network Meta-Analysis of Phase 3 Randomised Controlled Trials","volume":"43","author":"Haghdoost","year":"2023","journal-title":"Cephalalgia"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s10194-023-01585-2","article-title":"Effectiveness and Safety of Anti-CGRP Monoclonal Antibodies in Patients over 65 Years: A Real-Life Multicentre Analysis of 162 Patients","volume":"24","author":"Campoy","year":"2023","journal-title":"J. Headache Pain"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/ene.14715","article-title":"Long-Term Efficacy and Safety of Erenumab in Migraine Prevention: Results from a 5-Year, Open-Label Treatment Phase of a Randomized Clinical Trial","volume":"28","author":"Ashina","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s40122-024-00626-1","article-title":"Safety of Rimegepant in Adults with Migraine and Cardiovascular Risk Factors: Analysis of a Multicenter, Long-Term, Open-Label Study","volume":"13","author":"True","year":"2024","journal-title":"Pain Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.25831","article-title":"Anti-Migraine Calcitonin Gene-Related Peptide Receptor Antagonists Worsen Cerebral Ischemic Outcome in Mice","volume":"88","author":"Mulder","year":"2020","journal-title":"Ann. Neurol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s10194-019-0979-y","article-title":"CGRP and Migraine from a Cardiovascular Point of View: What Do We Expect from Blocking CGRP?","volume":"20","author":"Favoni","year":"2019","journal-title":"J. Headache Pain"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1177\/0333102419867282","article-title":"Erenumab (AMG 334), a Monoclonal Antagonist Antibody against the Canonical CGRP Receptor, Does Not Impair Vasodilatory or Contractile Responses to Other Vasoactive Agents in Human Isolated Cranial Arteries","volume":"39","author":"Ohlsson","year":"2019","journal-title":"Cephalalgia"},{"key":"ref_75","first-page":"e203","article-title":"Plasma CGRP Levels Are Not Associated With Collateral Flow and Outcome After Stroke","volume":"54","author":"Reidler","year":"2023","journal-title":"Stroke"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"173205","DOI":"10.1016\/j.ejphar.2020.173205","article-title":"The Effects of CGRP in Vascular Tissue\u2014Classical Vasodilation, Shadowed Effects and Systemic Dilemmas","volume":"881","author":"Sohn","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/HYPERTENSIONAHA.113.02517","article-title":"An Ongoing Role of \u03b1-Calcitonin Gene-Related Peptide as Part of a Protective Network against Hypertension, Vascular Hypertrophy, and Oxidative Stress","volume":"63","author":"Smillie","year":"2014","journal-title":"Hypertension"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/head.14051","article-title":"Hypertension: A New Safety Risk for Patients Treated with Erenumab","volume":"61","author":"Saely","year":"2021","journal-title":"Headache"},{"key":"ref_79","first-page":"e1897","article-title":"Blood Pressure in Patients with Migraine Treated with Monoclonal Anti-CGRP (Receptor) Antibodies: A Prospective Follow-up Study","volume":"99","author":"Terwindt","year":"2022","journal-title":"Neurology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0140-6736(90)90040-C","article-title":"Plasma CGRP in Acute Myocardial Infarction","volume":"335","author":"Mair","year":"1990","journal-title":"Lancet"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.npep.2005.11.005","article-title":"Release of Calcitonin Gene-Related Peptide from the Isolated Mouse Heart: Methodological Validation of a New Model","volume":"40","author":"Strecker","year":"2006","journal-title":"Neuropeptides"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/cvr\/24.3.239","article-title":"Improved Cardiac Performance with Human Calcitonin Gene Related Peptide in Patients with Congestive Heart Failure","volume":"24","author":"Gennari","year":"1990","journal-title":"Cardiovasc. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.peptides.2008.06.010","article-title":"Calcitonin Gene-Related Peptide-Mediated Antihypertensive and Anti-Platelet Effects by Rutaecarpine in Spontaneously Hypertensive Rats","volume":"29","author":"Li","year":"2008","journal-title":"Peptides"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1177\/0333102420941814","article-title":"The Potential Danger of Blocking CGRP for Treating Migraine in CADASIL Patients","volume":"40","author":"MaassenVanDenBrink","year":"2020","journal-title":"Cephalalgia"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0167-0115(85)90013-8","article-title":"Infusion of a Novel Peptide, Calcitonin Gene-Related Peptide (CGRP) in Man. Pharmacokinetics and Effects on Gastric Acid Secretion and on Gastrointestinal Hormones","volume":"10","author":"Kraenzlin","year":"1985","journal-title":"Regul. Pept."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/head.14095","article-title":"Pharmacokinetics and Safety of Ubrogepant When Coadministered with Calcitonin Gene\u2013related Peptide-Targeted Monoclonal Antibody Migraine Preventives in Participants with Migraine: A Randomized Phase 1b Drug\u2013Drug Interaction Study","volume":"61","author":"Jakate","year":"2021","journal-title":"Headache"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s40120-024-00586-w","article-title":"Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study","volume":"13","author":"Alsaadi","year":"2024","journal-title":"Neurol. Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/bph.16322","article-title":"Pharmacology of Erenumab in Human Isolated Coronary and Meningeal Arteries: Additional Effect of Gepants on Top of a Maximum Effect of Erenumab","volume":"181","author":"Dammers","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0271678X19882788","article-title":"Post-Stroke Remodeling Processes in Animal Models and Humans","volume":"40","author":"Cirillo","year":"2020","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ana.25679","article-title":"Predicting Upper Limb Motor Impairment Recovery After Stroke: A Mixture Model","volume":"87","author":"Selles","year":"2020","journal-title":"Ann. Neurol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/21\/11685\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:24:41Z","timestamp":1760113481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/21\/11685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":90,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["ijms252111685"],"URL":"https:\/\/doi.org\/10.3390\/ijms252111685","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,30]]}}}